EUR 9.02
(-3.43%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 12.17 Million EUR | 12.96% |
2022 | 16.37 Million EUR | -17.21% |
2021 | 19.77 Million EUR | 39.88% |
2020 | 14.13 Million EUR | 15.63% |
2019 | 12.22 Million EUR | 7.37% |
2018 | 11.38 Million EUR | 236.75% |
2017 | 3.38 Million EUR | 205.51% |
2016 | 1.1 Million EUR | -52.67% |
2015 | 2.33 Million EUR | 844.9% |
2014 | -314 Thousand EUR | -126.08% |
2013 | 1.2 Million EUR | -61.95% |
2012 | 3.16 Million EUR | 92.57% |
2011 | 1.64 Million EUR | 37.6% |
2010 | 1.19 Million EUR | 123.78% |
2009 | -5.02 Million EUR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 2.15 Million EUR | -83.26% |
2023 FY | 18.49 Million EUR | 12.96% |
2023 Q2 | 5.23 Million EUR | -58.23% |
2023 Q4 | 13.26 Million EUR | 153.65% |
2022 Q4 | 12.52 Million EUR | 225.08% |
2022 FY | 16.37 Million EUR | -17.21% |
2022 Q2 | 3.85 Million EUR | -65.64% |
2021 Q2 | 8.56 Million EUR | -23.77% |
2021 FY | 19.77 Million EUR | 39.88% |
2021 Q4 | 11.21 Million EUR | 30.85% |
2020 Q4 | 11.23 Million EUR | 287.38% |
2020 Q2 | 2.9 Million EUR | -69.83% |
2020 FY | 14.13 Million EUR | 15.63% |
2019 Q4 | 9.61 Million EUR | 265.8% |
2019 FY | 12.22 Million EUR | 7.37% |
2019 Q2 | 2.62 Million EUR | -69.33% |
2018 Q4 | 8.57 Million EUR | 204.15% |
2018 Q2 | 2.81 Million EUR | 30.77% |
2018 FY | 11.38 Million EUR | 236.75% |
2017 FY | 3.38 Million EUR | 205.51% |
2017 Q4 | 2.15 Million EUR | 75.63% |
2017 Q2 | 1.22 Million EUR | 0.0% |
2016 FY | 1.1 Million EUR | -52.67% |
2015 FY | 2.33 Million EUR | 844.9% |
2014 FY | -314 Thousand EUR | -126.08% |
2013 FY | 1.2 Million EUR | -61.95% |
2012 FY | 3.16 Million EUR | 92.57% |
2011 FY | 1.64 Million EUR | 37.6% |
2010 FY | 1.19 Million EUR | 123.78% |
2009 FY | -5.02 Million EUR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Biosynex SA | -37.4 Million EUR | 132.542% |
Predilife S.A. | -3.83 Million EUR | 416.987% |
bioMĂ©rieux S.A. | 439.1 Million EUR | 97.228% |
Eurofins Scientific SE | 717 Million EUR | 98.302% |